IBA Signs Contract With YAS Healthcare To Install Proton Therapy Center

Ion Beam Applications has signed a contract with YAS Healthcare (DAS Holding) to install a Proteus ONE compact proton therapy system in Dubai, creating the first operational proton therapy centre in the GCC; YAS expects to begin treating patients in 2029. IBA cites a typical end-user price for a Proteus ONE with a multi-year O&M contract of €35–45 million, and emphasises the platform is upgradeable; the stock closed up 1.96% at €11.44 on the Brussels exchange, signalling modest investor interest in the regional expansion and potential multi-year service revenues.

Analysis

Market structure: This deal directly benefits Ion Beam Applications (IBAB.BR / IOBCF) via ~€35–45m system revenue plus multi-year O&M annuity; regional hospital owners and construction contractors in GCC also gain. Competitors (Hitachi, Mevion, Siemens Healthineers SHL.DE, Elekta EKTA-B.ST) face pressure as single-room compact systems compete on capital intensity and footprint, shifting share toward lower-capex entrants in emerging markets. Expect lumpy but higher-margin service revenues over 3–7 years as upgrades and parts drive recurring cashflows.

Risk assessment: Key tail risks include installation delays, U.A.E. regulatory/licensing stalls, or reimbursement shortfalls causing >50% patient throughput misses vs forecasts — any of which could push revenue recognition past 2029. Near-term (days–months) market moves will be sentiment-driven; medium-term (6–24 months) depends on order backlog growth and 2025–2027 construction milestones; long-term (2029+) on patient volumes and upgrade monetization. Hidden dependencies: local financing, staffing of proton center, and cross-border patient flows (medical tourism) are critical second-order demand drivers.

Trade implications: Direct play: take a tactical long on IBAB.BR/IOBCF sized 2–4% of equity risk with clear stop (10% below entry); deploy 9–15 month call-spread (buy ATM, sell +20% strike) to cap premium. Pair trade: long IBAB.BR vs short 0.5–1% position in SHL.DE or EKTA-B.ST to express compact-proton share gains. Rotate 1–3% portfolio weight toward Healthcare Equipment and Emerging Markets Healthcare REITs while trimming large-cap diversified medical instrument exposure by 1–2%.

Contrarian angles: Market may underprice durable O&M annuities and upgrade TAM — each Proteus ONE could generate €2–5m/year in service revenue within 3–5 years, supporting higher long-term multiple. Conversely, reaction is possibly underdone on execution risk: if first GCC center underperforms, sentiment could reverse sharply; scale positions accordingly and re-evaluate on confirmed construction/licensing milestones (target: Q4 2025 confirmation).

Key Decisions for Investors

• Establish a 2–4% long position in Ion Beam Applications (IBAB.BR / IOBCF) within 30 days, targeting a 25–35% upside over 12–18 months; place a hard stop at 10% below entry and trim to half position if contract-delivery milestones are missed by >6 months.
• Implement a 9–15 month call spread on IOBCF/IBAB.BR: buy at-the-money call and sell a call ~20% above current price to limit premium; position size = 50% of the equity long to leverage upside while capping downside.
• Enter a pair trade: long IBAB.BR (2%) and short Siemens Healthineers (SHL.DE) or Elekta (EKTA-B.ST) (0.5–1%) to express expected market-share shift toward compact proton systems; rebalance after 6 months or on >15% relative performance divergence.
• Reduce exposure to large-cap diversified radiotherapy/hospital-capex names by 1–2% and redeploy into Emerging Markets healthcare equipment/clinic developers (1–3%); initiate buys on any IBAB.BR pullback to ≤€10 (≈12–15% retracement) and take profits at +25–35% or by end-2026.
• Monitor three specific catalysts over next 12 months before increasing size: (1) UAE construction permit and financing confirmation for YAS Healthcare within 6–12 months, (2) IBA announced order pipeline ≥€100m incremental in FY2025, (3) first service/installation milestones met by Q4 2026 — if any miss, halve position immediately.